Healthcare IT News January 16, 2018
Bill Siwicki

Continuous funding and partnerships – along with the potential for blockchain-based efforts to reduce the counterfeiting of drugs – are also changing the landscape a new report finds.

Pharmacy supply chain management to reduce drug counterfeiting were highlighted in the study.

The healthcare supply chain management market should reach $2.31 billion by 2022, up from $1.55 billion in 2017, according to a new study from ReportsnReports.com.

This growth will be driven by increased pressure on healthcare providers to improve operational efficiency and profitability, researchers said.

Key factors include the emergence of cloud-based systems, implementation of the unique device identification initiative by the U.S. Food and Drug Administration, the adoption of the GS1 System of standards in the healthcare industry globally...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Blockchain, FDA, Pharma
4 top healthcare CIOs: Forbes
Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development
Advancing Pharmacogenomics Education: Standardization and Opportunities in Pharmacy
Over Half of US Population Concerned About Prescription Drug Access, Prices
RFK Jr. vs. Vivek: Trump world's two paths for pharma regulation

Share This Article